Company / Free Cash Flow per Share
RIGEL PHARMACEUTICALS INC Free Cash Flow per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.43
FY2022
5-year range
-$0.43 / $0.03
FY2018-FY2022
Trend
-1494.4%
vs FY2021
Sector context
#83 of 192
Health Care
What the data says
Free Cash Flow per Share changed -1494% YoY in FY2022, a notable deviation from the 6-year average annual change of -220%.
Based on SEC 10-K filings.
-0.43 in FY2022.
Declined from $-0.32 to $-0.43 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 192 in Health CareTop 43% of 192This company -$0.43 Sector average $3.32
▼
-113.0% below sector average
Key checks
Key Insights
- In FY2022, free cash flow per share decreased 1494.4% year-over-year.
- Ranks #83 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$0.43 | -1494.4% |
| FY2021 | $0.03 | +109.7% |
| FY2020 | -$0.32 | -23.8% |
| FY2019 | -$0.26 | +50.8% |
| FY2018 | -$0.52 | +15.1% |
| FY2017 | -$0.62 | +24.3% |
| FY2016 | -$0.81 | -199.9% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026